共 32 条
[1]
Dunn KM(2004)Epidemiology and natural history of low back pain Eura Medicophys 40/1 9-13
[2]
Croft PR(2005)Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Pain 113 9-19
[3]
Dworkin RH(2001)The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents Arthritis Res 3/2 98-101
[4]
Turk DC(2000)Association between non-steroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s Arch Intern Med 160/14 2093-2099
[5]
Farrar JT(2012)The natural course of low back pain: a systematical critical literature review Chiropractic & Manual Therapies 20 33-161
[6]
Garcia Rodríguez LA(2007)Analgetische und muskeltonus-normalisierende Wirkung von Flupirtin retard bei chronischen Rückenschmerzen MMW Fortschr Med 149 153-18
[7]
Hernández-Díaz S(2003)Flupirtin bei muskuloskelettalen Schmerzen Fortschr Med 121 11-182
[8]
Hernández-Díaz S(1990)The pain disability index: psychometric properties Pain 40 171-1634
[9]
Rodríguez LA(2012)Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study Curr Med Res Opin 28/10 1617-1659
[10]
Lemeunier N(2011)Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European data-bases Gut 60/12 1650-S2046